The treatment of the morbidly anxious patient, by psychotherapy, should be confined to those who are emotionally and intellectually capable of co-operation, and a patient should not be accepted for treatment unless the diagnosis has been made on affirmative grounds, that is from the presence of the known characteristics of the state of disturbing and irresolute suspense which we describe as morbid anxiety. In making a diagnosis we aim at probabilities, approximations, rather than certainties; and the diagnosis may well be altered as we observe our patient. But this does not permit us to commence treatment on the basis of an ambiguous diagnosis or a negative diagnosis which infers psychological illness from the absence of organic disease. Whatever its form and whether combined with physical methods of treatment or not, psychotherapy is a co-operative procedure in which one person seeks to influence the health of another. It is essentially the interaction of two personalities. Jung (1933) puts the matter concisely: "By no device can the treatment be anything but the product of tht mutual influence in which the whole being"that is the personality, containing both conscious and unconscious elements-"of the doctor as well as that of the patient plays its part."
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The treatment of the morbidly anxious patient, by psychotherapy, should be confined to those who are emotionally and intellectually capable of co-operation, and a patient should not be accepted for treatment unless the diagnosis has been made on affirmative grounds, that is from the presence of the known characteristics of the state of disturbing and irresolute suspense which we describe as morbid anxiety. In making a diagnosis we aim at probabilities, approximations, rather than certainties; and the diagnosis may well be altered as we observe our patient. But this does not permit us to commence treatment on the basis of an ambiguous diagnosis or a negative diagnosis which infers psychological illness from the absence of organic disease. Whatever its form and whether combined with physical methods of treatment or not, psychotherapy is a co-operative procedure in which one person seeks to influence the health of another. It is essentially the interaction of two personalities. Jung (1933) puts the matter concisely: "By no device can the treatment be anything but the product of tht mutual influence in which the whole being"that is the personality, containing both conscious and unconscious elements-"of the doctor as well as that of the patient plays its part. " The relation of doctor and patient on a consciously harmonious level, as in our association with acquaintances, is described as "rapport". But when the unconscious of either doctor or patient is clearly involved, "transference" is a better term. Transference occurs whenever psychotherapy goes beyond the superficial level, and as it is a phenomenon of projection we cannot know to what extent the therapist and the patient will be involved. The interaction of the personality of the doctor and that of the patient means more than medical empathy, that is the doctor's ability to value the feelings of his patient, for the patient's valuation of the doctor's feelings also plays a part. The therapist will try to understand his patient and he must expect the patient to return the compliment. We encourage our patients to be natural, to drop pretences, knowing that the inner will affect the outer anyhow, and we should do the same. There is a danger that the analyst who has difficulty in making personal relations within or without the analytical sessions, may unknowingly protect himself behind the patient's manifestations of transference, denying his own part in the proceedings, although his projections, like those of his patient, are active ingredients. Successful psychotherapy is a joint effort, the product of the whole influence of each personality. While it is unreal to believe that every contact between therapist and patient is or should be within the transference situation (for rapport also provides possibilities of treatment), it is equally unreal for the therapist to regard transference as an abstraction with which he is not concerned. Whether he concerns himself with it or not, it will still be there, playing its part. My own opinion is that transference is of central importance, but that it is a mistake to make it the main focus of attention; nor need it always be analysed. It is a medium of contact, for good or ill, in which the Proceedings of the Royal Society of Mediine unconscious of the patient and that of the doctor can evolve and develop. Often the unspoken is more valuable than the spoken word.
The division of the neuroses into hysteria, anxiety and obsessional states, though deceptively simple, has one thing in its favour: it helps us to see that the energy, the drive behind psychoneurotic and similar symptoms, is differently directed, achieves its purpose in different ways. The attitudes, that is the activities represented in symptoms of neurosis, call for something more than an etiology framed solely on a simple developmental or cause and effect plan. In addition we should observe the attitude of the patient towards the movement of life, the passage of time. Bearing this in mind, I should place hysteria at one end of a scale and obsessional states at the other, with anxiety-states occupying an intermediate position. The patient with hysteria meets the present as if it were the past. In a fugue, for example, the dissociated individual wanders, not aimlessly but purposively, seeking to return to a place where once upon a time life was almost problemless; and should the morbid anxiety undergo conversion we have an attitude of dependence, even of childishness. It is this application of past notions to present problems which makes hysteria so resistant to treatment. On the other hand, the obsessional patient, who is always morbidly anxious, meets the present as though it were the future. The patient with the typical symptoms of an anxiety state falls between these two, for he is rooted in the present and cannot see either the past or the future in its true perspective. The relevance of these observations to the treatment of morbid anxiety will be illustrated if we consider some features in the group of patients with obsessional symptoms.
Three characteristics, usually found in combination, call for special attention in the treatment of obsessional patients: these are (1) a conscious sense of guilt; (2) secrecy regarding the symptoms-the obsessional neurosis is the secret neurosis; and (3) what for lack of a better term I call the time element.
(1) The patient with a compulsion to pursue repetitive actions or thoughts feels guilty and oppressed because of the content of his symptoms, which nevertheless fascinate him. Consciously he loathes his acts or thoughts, yet their interest-value compels him to cling to them, and at the same time the conscious sense of guilt permits him to feel exonerated from the burden of responsibility for them. In consequence he has an insoluble problem: his conscious sense of guilt imparts a feeling of righteousness because of the condemnation of his compulsions, thus enabling him at the same time to own and yet to disown the satisfaction which his interest provides. The creation of an insoluble problem, such as this, is indeed one of the characteristics of the obsessional neurosis.
(2) The existence of the neurosis is a closely guarded secret and insulates him from others. But the secretiveness has its value, for like the guilt it preserves the symptoms, and close friends or relatives may be unaware that the patient has any symptoms, let alone their nature.
(3) Morbid anxiety in the obsessional patient is anxiety about the future on which his eyes are fixed almost to the exclusion of the present. His symptoms are an attempt to influence the future by magical thinking. Filled with morbid expectation he is deeply concerned with the passage of time. A patient of mine had a phobia concerning clocks and particularly clocks which struck the hour: "Time runs, the clock will strike." The striking of the clock sounded a note of inevitability-the time had come for something to happen. "Time, the subtle thief of youth" provides the insoluble problem of the obsessional, for all obsessional rituals aim at making time stand still. Behind the neurosis lies a morbid fear of the future and with it the thought of death. Thus the obsessional with a show of efficiency over current affairs (which deceives himself and others) is surprisingly ineffective. Intellectually he is often gifted but, being all for delay, he falls short of the goal which his attainments warrant. In him we see the hidden wish that "time may cease and midnight never come". More than any other, the obsessional patient is hurt and hindered by morbid anxiety and I suggest that the consideration of these three characteristics -the sense of guilt, secrecy and the time element-give an insight into his mind which is invaluable in treatment. It is difficult to understand how anyone can treat an obsessional neurosis, or any neurosis, purely by a reductive technique.
When it is possible-and often it is-to help a patient (obsessional or otherwise) to see the state of affairs behind the morbid anxiety with which his symptoms are clouded, then he has taken the first step towards being a more effective and much less anxious individual.
He acquires a respect for his mind, conscious and unconscious, in its personal and impersonal aspects. To achieve this enlargement of consciousness we give the chief place in the treatment of morbid anxiety to dream analysis and to the use of drawings and paintings to amplify the dreams and particularly their symbolic content, as well as the products of active imagination. The patient is thus in the treatment, sharing the work with the therapist. Consequently the interviews can be spaced out, often being weeks apart, till the patient, no longer bound by morbid anxiety, takes over responsibility for himself. Dr. H. J. Shorvon: The appreciation of the physiological basis of anxiety, as well as the psychological, and the viewpoint that much morbid anxiety is the result of conditioning, has led to the approach whose aim is the disrupting of conditioned patterns of anxiety by chemical or other means.
Before and during the First World War there were only psychotherapy, hypnosis, bromides, paraldehyde and opiates. Barbiturates were not used before 1930. Sodium amytal in 1930 and Seconal in 1935 were the first of the barbiturates to come on to the market. Drug abreaction techniques were developed during the last war, first with intravenous barbiturates in 1940, and then under open ether by Palmer in North Africa and later by Sargant and myself at the time of the Normandy campaign. Modified insulin for sedative and nutritional purposes was first used on a large scale by Sargant at the time of Dunkirk. In 1944 Rogerson introduced the inhalation of nitrous oxide for abreactive and psychotherapeutic purposes, and in 1948 Meduna began his passive treatment of anxiety states by the repeated inhalations of a 30% carbon dioxide mixture. Sargant introduced intravenous Methedrine as an abreactive agent in 1948, and L6pez-Ibor in Spain in 1950 found intravenous acetylcholine of value in certain types of tension. In 1950 Hirschfeld and Alexander in America tried subconvulsive electrical stimulation for the treatment of tension states, and this therapy was established in this country soon after by Spencer Paterson. Also since the war, the antihistaminic drugs such as Phenergan have developed and played an important part in treatment. In the past few years many "tranquillizers" have appeared on the market. The word is meant to indicate a drug which will ease anxiety and psychomotor agitation without affecting consciousness to any extent.
The personality of the patient, the intensity of his symptoms and whether his morbid anxiety is a manifestation of an anxiety state or secondary to some other disorder, such as melancholia, an obsessional state, &c., must be assessed before the value of the particular tranquillizer can be judged. Some random observations on the use of these drugs may not come amiss. Bromides may be very useful in easing severe tension, but are apt to aggravate depression, and should be avoided in the aged, especially where renal function is impaired. I have recently seen two cases of addiction and repeated overdosage with Persomnia tablets, which unfortunately can be bought over the counter. They showed tremors, acneiform eruptions, ataxia, and spells of confusion with paranoid ideas and hallucinations.
The short-acting barbiturates have no superior in easing morbid anxiety. Addiction is rare although habit formation is commoner, and patients usually cut down the prescribed dose on their own initiative. Unfortunately, excessive dosage over a prolonged period may engender or exacerbate anxiety instead of relieving it. Seconal, i grain, and sodium amytal, 1 grain, are the most effective drugs for immediate relief of acute panic or fear. The use of barbiturates in continuous narcosis is well known, but care must be taken in their withdrawal, particularly in obsessional personalities who may even show schizophreniclike symptoms for a few days. I rarely use long-acting barbiturates such as phenobarbitone in the treatment of anxiety, because of depressant effects.
Antihistaminic drugs such as Phenergan are useful, particularly with patients in bed who tolerate 150-300 mg. daily, and I have also found the drugs of value in the relief of tension in sufferers from generalized pruritus and other psychosomatic disorders. They combine well with chlorpromazine in controlling agitation and restlessness.
Chlorpromazine or Largactil, the first of the tranquillizers, has been tried extensively since 1952. Most ambulant patients dislike it as they often feel tired and derive little easing of tension. Linford Rees and Lambert did, however, find that 50% of 150 patients showed considerable clinical improvement although two-thirds relapsed within a few weeks despite continued medication. Jaundice is an important complication, usually occurring within the first ten days of taking small doses. The drug, however, is very useful in in-patient treatment of acute anxiety reactions and for acute psychotic illnesses such as manic or schizophrenic excitement if given in bigger doses of 50-100 mg. three times a day, or more. It combines well with barbiturates in continuous narcosis, and is useful in combating a post-E.C.T. flare-up of tension or damping down the anxiety of the agitated melancholic. A feature is its tendency to increase appetite, and gratifying results 'are often obtained when combined with modified insulin.
Mephazine or Pacatal is chemically related to chlorpromazine and is said to have fewer side effects apart from dryness of mouth and blurring of vision. I have found it useful in easing tension of patients suffering from involutional depression who are not responding to E.C.T.
Reserpine or Serpasil, a rauwolfia alkaloid, can be regarded as still on trial. It is mildly hypotensive, and useful in patients suffering from hypertension with anxiety. In large doses of 8-10 mg. daily it can control the motor over-activity and aggressiveness of manic and schizophrenic excitements. Toxic side effects, Parkinsonism and cedema are not uncommon complications. Depression is a serious risk in patients on large doses. I use it very little in out-patients because of the un'pleasant side-effects of tiredness, congestion of nose, diarrhoea and depression, but, like chlorpromazine, it tends to increase appetite and has been useful in conjunction with modified insulin in treating anorexia nervosa.
More recent tranquillizers, part of the feverish search for a panacea for anxiety, include, benactyzine compounds (Suavitil, Nutinal, and Covatin), the meprobamates (Equanil, Miltown, and Mepavlon) and hydroxyzine compounds such as Atarax. Little is known of their pharmacological or possible harmful effects. Suavitil has received enthusiastic notice in Scandinavian papers by Jacobsen, Munkvad, &c., and in the British Medical Journal by Davies. It is said to produce a barrier between the patient and his problems. Lieberman and Vaughan in a recent paper consider this drug the best of the newer tranquillizers in the treatment of diffuse non-specific anxiety and tension. I have not found this to be the case with the majority of my out-patients on this drug, and indeed most anxiety patients asked to be taken off it. I used a total of 3 mg. daily. At St. Thomas's Hospital, da Fonseca and West carried out a trial of benactyzine and found it useful in anxiety reactions due to environmental stre4s and panic attacks in obsessive personalities. They, too, were disappointed with the overall results. Perhaps the most widely used new tranquillizer is meprobamate, despite its cost. According to West and da Fonseca, Miltown has become the fourth most commonly prescribed drug in America and there is no doubt that Equanil, the same drug in England, is greatly in demand. The chemical formula is closely related to mephenesin, and in doses of 400 mg. (one tablet) three times a day it has been hailed in the U.S.A. as the drug for reducing morbid tension and anxiety because of its muscle relaxant and sedative effects. It is also said to be a fifth as toxic as barbiturates and not liable to create addiction. West and da Fonseca in the Psychiatric Department of St. Thomas's carried out three separate controlled trials. They found that 58% of patients classified as anxious and tense were helped. The results were not so good as those claimed by American workers. The relief was in the subjective sphere rather than in overt somatic manifestations of anxiety. Meprobamate was also compared with sodium amytal in a further series but no marked differences were found in effectiveness between these two drugs. However, clinically, meprobamate often seems more useful than a barbiturate when irritability is a marked feature. No serious side effects were observed. It therefore appears that Equanil has the beneficial effects of barbiturates, but with less risk of toxic complications and addiction. Although I have not carried out statistical trials, I have used meprobamate on a large scale in a variety of psychiatric syndromes and found it a useful drug in the out-patient treatment of anxiety states, particularly phobic states, fears of insomnia, and other mono-symptomatic fears. I have often seen the drug slow down feelings of impatience and frustration, but it also increased dullness in the morning and depression. It is best avoided where a depressive element is present in the illness. It also appears to reinforce the effect of barbiturates, and is therefore useful when added to such hypnotics at night, in order to reduce the total barbiturate consumption and to facilitate sleep.
A combination of stimulant and sedative drugs, for instance, Drinamyl, is particularly helpful in phobic anxiety states in an obsessional setting. The obsessional patient feels at his best when cortically stimulated, yet soothed at the same time. The result is activity in a relaxed and optimistic mood.
L6pez-Ibor in 1950 introduced repeated intravenous acetylcholine injections in' the treatment of tension states. Sargant, Phillips and Hutchinson found it useful with patients of good personality suffering from phobic tension states, particularly in driving personalities who carried on their work despite periods of debility. Hawkings and Tibbetts have questioned these results, but their clinical material does not appear to correspond.
Abreactive techniques were fully discussed in papers in the R.S.M. in 1950 and 1953. Intravenous barbiturates were first used at the time of Dunkirk, and the excitatory abreaction of traumatic experiences in people of reasonably good previous personalities facilitated an emotional release, and often prevented the implantation of recently acquired neurotic patterns of behaviour. Soldiers in a state of acute fear and showing tics and violent movements of all kinds, in addition to hysterical inhibitory phenomena such as amnesia, aphonia and paralysis, felt "a load off their minds" after effective abreaction. It was usually necessary to follow this up with adequate sedcation for some days, if the patient was to emerge into, and remain in, a state of mental equilibrium. This approach is, of course, equally useful in the treatment of anxiety states following traumatic episodes in civilian life. It was found later in the war that in untreated or inadequately treated cases, the neurotic reactions had become firmly established as a result of anxious rumination over unrelieved traumatic incidents.
Intravenous barbiturates failed to reactivate the affect attached to those experiences, and a dull recital of facts ensued, without benefit to the patient. During the Normandy campaign ether inhalation on an open ether mask was found to produce stronger excitatory abreactions in the acute psychiatric battle casualties than the barbiturates, with a correspondingly greater relief of anxiety and tension. Similar difficulties with the intravenous barbiturates were again experienced in more chronic cases, but the occasional ether abreaction still may be a useful procedure from time to time in the treatment of chronic anxiety states where traumatic incidents have played an obvious part in the precipitation of symptoms. The most difficult patients to treat, the anxious obsessionals, may be helped by intravenous Methedrine in small doses of about 15 to 20 mg., used either as a psycho-therapeutic aid or for encouraging abreaction. The drug relaxes the patient and reduces inhibition by cortical stimulation, so that everything is discussed with a feeling of confidence in extra-clear consciousness. Barriers are rapidly broken down, much repressed material is brought to the surface, and a good deal of tension is released over a period of time.
I also find that psychotherapy with the aid of intravenous Methedrine, and the occasional use of ether abreaction where there is some resistance to be overcome, or traumatic incidents to be discussed, is one of the best ways of treating phobic anxiety states with panic attacks, and psychosomatic disorders, such as skin disturbances resulting from emotional factors.
The pharmacological and clinical actions of the older drugs, bromides and barbiturates, have now been fairly well worked out, but few controlled studies have yet been carried out with the host of new tranquillizers. Little is known therefore about their mode of action and the indications for their use. Some may prove useful, and I suspect the majority will be discarded in time as the evidence about their value is slight.
